维普中文期刊产品整合服务
100篇 您的检索式:作者名="Grandone"
    题名 作者 年代 出处 被引量
1Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics显示文摘Classically, the non-alcoholic fatty liver disease(NAFLD) physiopathology and progression has been summarized in the two hits hypothesis. The first hit is represented by the action of hyperinsulinemia and insulin resistance, accompanying obesity, that leads to liver steatosis increasing the absolute non esterified fatty acids uptake in the liver and the esterification to form triacylglycerol. The oxidative stress is involved in the second hit leading to the progression to nonalcoholic steatohepatitis(NASH) because of its harmful action on steatosic hepatocytes. However, at the present time, the two hits hypothesis needs to be updated because of the discover of genetic polymorphisms involved both in the liver fat accumulation and progression to NASH that make more intriguing understanding the NAFLD pathophysiological mechanisms. In this editorial, we want to underline the role of PNPLA3 I148 M, GPR120 R270 H and TM6SF2 E167 K in the pediatric NAFLD development because they add new pieces to the comprehension of the NAFLD pathophysiological puzzle. The PNPLA3 I148 M polymorphism encodes for an abnormal protein which predisposes to intrahepatic triglycerides accumulation both for a loss-of-function of its triglyceride hydrolase activity and for a gain-of-function of its lipogenic activity.Therefore, it is involved in the first hit, such as TM6SF2 E167 K polymorphisms that lead to intrahepatic fat accumulation through a reduced very low density lipoprotein secretion. On the other hand, the GPR120 R270 H variant, reducing the anti-inflammatory action of the GPR120 receptor expressed by Kuppfer cells, is involved in the second hit leading to the liver injury.Pierluigi Marzuillo Anna Grandone Laura Perrone Emanuele Miraglia del Giudice 2015World Journal of Hepatology2015,7,11:9
2TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype显示文摘AIM To evaluate the impact of the Glu167Lys(E167K) transmembrane 6 superfamily member 2(TM6SF2) variant on the biochemical and morphologic expression of liver lesions in human immunodeficiency virus(HIV)/hepatitis C virus(HCV) co-infected patients.METHODS The study comprised 167 consecutive patients with HIV/HCV coinfection and biopsy-proven chronic hepatitis. A pathologist graded liver fibrosis and necroinflammation using the Ishak scoring system, and steatosis using Kleiner's scoring system. Patients were genotyped for TM6SF2 E167K(rs58542926) by real-time Polymerase chain reaction. The 167 patients, 35 therapy-naive and 132 receiving ART, were prevalently males(73.6%), the median age was 40.7 years and the immunological condition good(median CD4+ cells/mm3 = 505.5).RESULTS The 17 patients with the TM6SF2 E167 K variant, compared with the 150 with TM6SF2-E/E, showed higher AST(P = 0.02) and alanine aminotransferase(P = 0.02) and higher fibrosis score(3.1 ± 2.0 vs 2.3 ± 1.5, P = 0.05). In a multivariate analysis, TM6SF2 E167 K was independently associated with severe fibrosis. The same analysis showed that HCV-genotype 3, present in 42.2% of patients was an independent predictor of severe steatosis. The association of TM6SF2 E167 K with severe steatosis, absent for the whole group of 167 patients, was re-evaluated separately for HCVgenotype 3 and non-3 patients: No factor was independently associated with severe steatosis in the HCV-genotype-3 subgroup, whereas an independent association was observed between severe steatosis and TM6SF2 E167 K in non-3 HCV genotypes. No association between the TM6SF2 E167 K variant and severe liver necroinflammation was observed.CONCLUSION In HIV/HCV coinfection the TM6SF2 E167 K variant is an independent predictor of severe fibrosis, but appears to be independently associated with severe steatosis only for patients with a non-3 HCV genotype.Caterina Sagnelli Marco Merli Caterina Uberti-Foppa Hamid Hasson Anna Grandone Grazia Cirillo Stefania Salpietro Carmine Minichini Mario Starace Emanuela Messina Patrizia Morelli Emanuele Miraglia Del Giudice Adriano Lazzarin Nicola Coppola Evangelista Sagnelli 2016World Journal of Gastroenterology2016,22,38:4
3TM 6 SF 2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA 3 polymorphism显示文摘Nicola Coppola Zampino Rosa Grazia Cirillo Maria Stanzione Margherita Macera Adriana Boemio Anna Grandone Mariantonietta Pisaturo Aldo Marrone Luigi E. Adinolfi Evangelista Sagnelli Emanuele Miraglia del Giudice 2015Liver Int2015,,8:3
4Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis显示文摘Lucio Amitrano Maria Anna Guardascione Vincenzo Brancaccio Maurizio Margaglione Francesco Manguso Luigi Iannaccone Elvira Grandone Antonio Balzano 2004Journal of Hepatology2004,,5:2
5Homocysteine levels in amniotic fluid显示文摘Grandone E Colaizzo D Vecehione G 2006Relationship with birth-weight Thromb Haemost2006,95,4:1
6Determining sulfor-containing amino acids by capillary electrophoresis: a fast novel method for total homocysteine human plasma 显示文摘 Margaglione M Grandone E 1999Electrophoresis1999,20,3:1
7Electronic commerce adoption: an empirical study of small and medium US businesses 显示文摘Grandon E E Pearson J M 2004Information & Management2004,42,1:1
8Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward:relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes显示文摘Margaglione M Grandone E Vecchione G 1997Arterioscler Thromb Vasc Biol1997,17,10:1
9Electrocoagulation as a Remediation Tool for Wastewaterscontaining Arsenicv显示文摘Henrik K Hansen Patricio Nuez Rodrigo Grandon 2006Minerals Engineering2006,19,:1
10Determining sulfor-containing amino by capillary electrophoresis:a fast novel mothod for total homocysteine human plasma显示文摘Vecchione G Margaglione M Grandone E 1999Electrophoresis1999,20,3:1
11Genetic Modulation of Plasma Fibrinogen Concentrations:Possible Importance of Interleukin-6显示文摘Margaglione M Grandone E Mancini FP el al 1996J Thromb Thrombolysis1996,3,1:1
12Clinical evaluation of hexagonal keratotomy for the treatment of primary hyperopia 显示文摘Grandon SC Sanders DR Anello RD 1995J Cataract Refract Surg1995,21,:1
13Novel cAMP binding protein-BP (CREBBP) mutation in a girl with Rubinstein-Taybi syndrome,GH deficiency,Arnold Chiari malformation and pituitary hypoplasia显示文摘Marzuillo P Grandone A Coppola R 2013BMC Med Genet2013,14,:1
14Electronic commerce adoption: an empirical study of small and medium US businesses 显示文摘Grandon E E Pearson J M 2004Information & management2004,42,1:1
15The C677T methyle- netetrahydrofolate reductase gene mutation does not influence cardiovas- cular risk in the dialysis population : results of a multicentre prospective study 显示文摘Aucella F Margaglione M Grandone E et at 2005Nephrol Dial Transplant2005,20,2:1
16Subclinical myocardial dysfunction and cardiac autonomic dysregulation are closely associated in obese children and adolescents:the potential role of insulin resistance显示文摘Cozzolino D Grandone A Cittadini A 2015PLo S One2015,10,01:1
17Electronic Commerce Adoption: An Empirical Study of Small and Medium US Businesses显示文摘Grandon E E Pear on J M 2004Informa- tion & Management2004,42,1:1
18Genetic modulation of plasma fibrinogen concentrations:possible importance of interleukin -6显示文摘Margaglione M Grandone E Mancini FP 1996J Thromb Thrombolysis1996,3,:1
19Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke 显示文摘Margaglion M Di Minno G Grandone E 1994Arteriosclerosis1994,14,:1
20Genetic modulation of oral anticoagulation with warfarin显示文摘Margaglione M Colaizzo D D'Andrea G Brancaccio V Ciampa A Grandone E 2000Thromb Haemost2000,84,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费